Allison Jeynes-Ellis

Allison Jeynes-Ellis, MD, FFPM (UK), is a trained clinician with more than 25 years of senior leadership experience in the pharmaceutical industry. She currently serves as Chief Executive Officer at Avillion LLP, a London-based drug development company focused on co-development and financing of late-stage pharmaceuticals, where she is responsible for identifying high-potential opportunities to fund programs to approval. She previously led development at Wyeth, BMS, Novartis, and GSK and has secured numerous U.S. and EU drug approvals.